DE68901085D1 - Verwendung von substituierten benzamiden zur stimulierung der gastromotorik. - Google Patents

Verwendung von substituierten benzamiden zur stimulierung der gastromotorik.

Info

Publication number
DE68901085D1
DE68901085D1 DE8989403431T DE68901085T DE68901085D1 DE 68901085 D1 DE68901085 D1 DE 68901085D1 DE 8989403431 T DE8989403431 T DE 8989403431T DE 68901085 T DE68901085 T DE 68901085T DE 68901085 D1 DE68901085 D1 DE 68901085D1
Authority
DE
Germany
Prior art keywords
gastromotorics
stimulate
substituted benzamides
benzamides
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8989403431T
Other languages
English (en)
Inventor
Jacques Acher
Jean-Claude Monier
Jean-Paul Schmitt
Renee Gardaix-Luthereau
Brenda Dr Costall
Robert Dr Naylor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratoires Delagrange SA
Original Assignee
Laboratoires Delagrange SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Delagrange SA filed Critical Laboratoires Delagrange SA
Application granted granted Critical
Publication of DE68901085D1 publication Critical patent/DE68901085D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/28—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/18—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
DE8989403431T 1988-12-14 1989-12-12 Verwendung von substituierten benzamiden zur stimulierung der gastromotorik. Expired - Lifetime DE68901085D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8816433A FR2640139A1 (fr) 1988-12-14 1988-12-14 Application de benzamides substitues comme gastromoteurs

Publications (1)

Publication Number Publication Date
DE68901085D1 true DE68901085D1 (de) 1992-04-30

Family

ID=9372914

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8989403431T Expired - Lifetime DE68901085D1 (de) 1988-12-14 1989-12-12 Verwendung von substituierten benzamiden zur stimulierung der gastromotorik.

Country Status (9)

Country Link
US (1) US5116857A (de)
EP (1) EP0374029B1 (de)
JP (1) JPH02237928A (de)
AT (1) ATE73997T1 (de)
CA (1) CA2005442A1 (de)
DE (1) DE68901085D1 (de)
DK (1) DK613989A (de)
FR (1) FR2640139A1 (de)
GR (1) GR3004350T3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770262B2 (en) * 2000-03-30 2004-08-03 Questcor Pharmaceuticals, Inc. Nasal administration of agents for the treatment of gastroparesis
US6662951B1 (en) * 2000-09-27 2003-12-16 Basic Resources, Inc. Process for extracting and purifying naturally occurring zeolite
US20130213393A1 (en) 2009-12-22 2013-08-22 Evoke Pharma, Inc. Nasal formulations of metoclopramide
US8334281B2 (en) * 2008-12-22 2012-12-18 Evoke Pharma, Inc. Nasal formulations of metoclopramide
EP3554489A4 (de) 2016-12-15 2020-06-17 Evoke Pharma, Inc. Behandlung von mässiger bis schwerer gastroparese

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL281394A (de) * 1961-07-25
CA1082181A (en) * 1976-06-03 1980-07-22 Eric A. Watts Benzamide derivatives
US4188393A (en) * 1977-04-22 1980-02-12 Sandoz Ltd. Treating spastic conditions or relaxing muscles
US4714707A (en) * 1984-01-13 1987-12-22 Rorer Pharmaceutical Corporation Aryl substituted heterocycles for treating gastrointestinal motility dysfunction
JPH0710771B2 (ja) * 1984-10-23 1995-02-08 ナステツク フア−マス−テイカル カンパニ−、インコ−ポレイテツド 抗吐き気および抗嘔吐薬剤の新規な投与組成物
GB8519707D0 (en) * 1985-08-06 1985-09-11 Fordonal Sa Chemical compounds
FR2592042B1 (fr) * 1985-12-19 1988-03-25 Ile De France Nouveaux ortho-anisamides, leur procede d'obtention, et leurs applications therapeutiques
US4870074A (en) * 1986-04-30 1989-09-26 Dainippon Pharmaceutical Co., Ltd. Substituted benzamide derivatives, for enhancing gastrointestinal motility
EP0295350B1 (de) * 1987-06-17 1992-11-11 Laboratoires DELAGRANGE Anwendung von N-[2-(diäthylamino)äthyl]-2-methoxy-4[(1-H-4,5-dihydro-2-imidazolyl)amino]-5-chlorobenzamid als anxiolytisches und antipsychotisches Mittel
GB8718345D0 (en) * 1987-08-03 1987-09-09 Fordonal Sa N-substituted benzamides

Also Published As

Publication number Publication date
JPH02237928A (ja) 1990-09-20
DK613989A (da) 1990-06-15
EP0374029B1 (de) 1992-03-25
US5116857A (en) 1992-05-26
FR2640139A1 (fr) 1990-06-15
CA2005442A1 (fr) 1990-06-14
EP0374029A1 (de) 1990-06-20
ATE73997T1 (de) 1992-04-15
GR3004350T3 (de) 1993-03-31
DK613989D0 (da) 1989-12-06

Similar Documents

Publication Publication Date Title
ES2065880T3 (es) Proteina quimicamente modificada y obtencion de la misma.
DE3169160D1 (en) Amino-acids derivatives and their therapeutic use
SE7906722L (sv) Merkaptoacylderivat av substituerade proliner
DK0571471T3 (da) 5-Heteroylindolderivater
DK0502169T3 (da) Piperazinderivater
NO892579D0 (no) Heterocykliske forbindelser.
ES2040879T3 (es) Procedimiento de preparacion de derivados pirimidinilaminicos de piperidina.
DK429089D0 (da) Alkylbenzylaminer
SE8503207L (sv) Farmakologiskt aktiva substituerade bensamider
ATE73997T1 (de) Verwendung von substituierten benzamiden zur stimulierung der gastromotorik.
ES538339A0 (es) Procedimiento para la obtencion de o-glicosilamidas sustituidas
DK640687A (da) Allylmercaptoacetylsydnoniminer, deres fremstilling og anvendelse
DE3787796D1 (de) Anwendung heterozyklischer Derivate zur Herstellung von Arzneimitteln.
DK440987A (da) Thyroninderivater, deres fremstilling og anvendelse
DK0445013T3 (da) N-Cycloalkylalkylaminer, fremgangsmåde til fremstilling deraf, deres anvendelse som lægemiddel og deres syntese-mellemprodukter
PT90490A (pt) Processo para a preparacao de acidos aromaticos e do dispositivo que os utiliza
PT86852A (pt) Procede de preparation des nouveaux acetamides derives de la dihydro-2,3 phenyl-3 benzofurannone-2
SE8704551D0 (sv) New benzo(g)quinolines
DE3565265D1 (de) Benzoyl ureas

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee